Ltd.;Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.;Institute of Materia Medica, Chinese Academy of Medical Sciences;Jiangsu Tasly Diyi Pharmaceutical Co.
发明人:
Zhu, Haibo,Shi, Huijie
申请号：
AU2016383376
公开号：
AU2016383376A1
申请日:
2016.12.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention provides a triacetyl-3-hydroxyphenyladenosine represented by formula (I) for preventing or treating non-alcoholic fatty liver. The triacetyl-3-hydroxyphenyladenosine can significantly reduce levels of serum AST, ALT, and TG, significantly improve liver functions, and alleviate liver steatosis. The invention provides significant curative effects for preventing or treating non-alcoholic fatty liver and has limited toxic side effects.
